All posts tagged
French Biotech Gets a CRISPR Patent for CAR-T Research
Why Does Europe Lag Behind the US and China in the Gene Editing Race?
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Would you Taste this Gene-Edited Dinner?
Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”
Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer
Cellectis will work from New York to become a CAR-T leader
Labiotech UG, All Rights Reserved -